Ligand Pharmaceuticals
(NASDAQ) LGND
Ligand Pharmaceuticals Financials at a Glance
Market Cap
$3.90B
Revenue (TTM)
$268.09M
Net Income (TTM)
$124.45M
EPS (TTM)
$5.83
P/E Ratio
33.50
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$195.66
Volume
6,979
Open
$201.86
Price
$195.66
Volume
6,979
Open
$201.86
Previous Close
$195.66
Daily Range
$194.70 - $204.65
52-Week Range
$93.58 - $227.92
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$195.66
Volume
6,979
Open
$201.86
Previous Close
$195.66
Daily Range
$194.70 - $204.65
52-Week Range
$93.58 - $227.92
LGND News
LGND: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ligand Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
47
CEO
Todd Christopher Davis, MBA
Website
www.ligand.comHeadquarters
Jupiter, CA 94608, US
LGND Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
18%
Net Income Margin
46%
Return on Equity
13%
Return on Capital
3%
Return on Assets
8%
Earnings Yield
2.99%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.90B
Shares Outstanding
19.94M
Volume
6.98K
Short Interest
0.00%
Avg. Volume
220.98K
Financials (TTM)
Gross Profit
$261.50M
Operating Income
$47.20M
EBITDA
$192.74M
Operating Cash Flow
$49.36M
Capital Expenditure
$452.00K
Free Cash Flow
$48.91M
Cash & ST Invst.
$733.52M
Total Debt
$451.49M
Ligand Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$59.67M
+39.4%
Gross Profit
$85.65M
+114.3%
Gross Margin
1.44%
N/A
Market Cap
$3.90B
N/A
Market Cap/Employee
$57.32M
N/A
Employees
68
N/A
Net Income
$44.78M
+244.1%
EBITDA
$66.40M
+323.7%
Quarterly Fundamentals
Net Cash
$282.03M
+13.2%
Accounts Receivable
$61.05M
+43.8%
Inventory
$9.13M
-35.3%
Long Term Debt
$450.40M
+7645.4%
Short Term Debt
$1.09M
-15.1%
Return on Assets
7.97%
N/A
Return on Invested Capital
3.10%
N/A
Free Cash Flow
$45.84M
+65.1%
Operating Cash Flow
$45.84M
+61.0%